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Abstract
 
G protein signaling via the G
 
 
 
12 family (G
 
 
 
12 and G
 
 
 
13) has not been well studied in T cells.
To investigate whether G
 
 
 
12 and G
 
 
 
13 are involved in thymopoiesis, we expressed the regu-
lator of G protein signaling domain of p115RhoGEF to inhibit G
 
 
 
12 and G
 
 
 
13 during thy-
mopoiesis. Fetal thymus organ cultures seeded with p115
 
 
 
DH-expressing progenitor cells
showed impaired thymopoiesis with a block at the CD4
 
 
 
CD8
 
 
 
CD44
 
 
 
CD25
 
 
 
 (DN3) stage.
Using G
 
 
 
13 or G
 
 
 
12 minigenes, we demonstrated that G
 
 
 
13, but not G
 
 
 
12, is required for
thymopoiesis. T progenitor cells expressing p115
 
 
 
DH showed reduced proliferation and in-
creased cell death. T cell receptor stimulation of the fetal thymus organ cultures did not rescue
the block. Overexpression of the antiapoptotic gene Bcl2 rescued the defect in DN3 cells and
partially rescued T cell development. Therefore, G
 
 
 
13-mediated signaling is necessary in early
thymocyte proliferation and survival.
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Introduction
 
Developing T cells undergo a highly regulated process of
selection in the thymus before exiting the organ and mi-
grating to secondary lymphoid tissues. Hematopoietic stem
cells or common lymphoid progenitor cells move to the fetal
liver during early gestation or the bone marrow later in
development and then home to the thymus (1, 2) to begin
the process of committing to the T cell lineage (3). The
most abundant cells in a normal thymus are double positive
(DP) thymocytes, which express both CD4 and CD8 recep-
tors. DP cells go through a process of positive selection
whereby the TCR
 
 
 
 chain rearranges. Only T cells that
produce a TCR capable of recognizing either MHC I or
MHC II and transducing a signal are able to survive. The
surviving thymocytes then proceed through negative selection
to eliminate cells that respond too strongly to the presentation
of self antigen, preventing the release of autoreactive single
positive mature T cells into the periphery (4, 5). However,
before thymocytes express CD4 and CD8 and begin the
crucial process of selection they must progress through
four double negative (DN) stages of development defined
by the expression of CD44 and CD25: CD44
 
 
 
CD25
 
 
 
(DN1), CD44
 
 
 
CD25
 
 
 
 (DN2), CD44
 
 
 
CD25
 
 
 
 (DN3),
and CD44
 
 
 
CD25
 
 
 
 (DN4) (6–8). DN2 stage cells initiate
rearrangement of the TCR
 
 
 
 chain, which is completed
during the DN3 stage. TCR
 
 
 
 pairs with the pre–T
 
 
 
 chain
to form a functional pre-TCR (9). Successful 
 
 
 
 chain rear-
rangement as measured by efficient signaling through the
pre-TCR results in significant expansion of the DN3 cells
and down-regulation of CD25 as the cells move to DN4
(7, 10). IL-7 and c-kit signaling are also important for survival
of DN thymoyctes, whereas Notch signaling is required for
differentiation of both DN and DP thymocytes at several
stages of development (11). In addition, other signaling path-
ways, including G protein–coupled receptors (GPCRs), are
implicated in controlling thymocyte survival, differentia-
tion, and proliferation (12–14).
G protein–coupled receptors play a key role in enabling
T cells to react to a variety of external signals ranging
from developmental cues to chemotactic molecules. GPCRs
transduce signals through their direct interaction with mem-
bers of the heterotrimeric G protein families: G
 
 
 
i, G
 
 
 
s,
G
 
 
 
q, and G
 
 
 
12. Research into GPCR function in T cells
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has focused primarily on a subfamily of GPCRs known as
chemokine receptors. Chemokine receptor signaling pri-
marily utilizes the G
 
 
 
i pathway, which plays a particularly
important role in both development and inflammation
(15). Thymic treatment with pertussis toxin, an inhibitor of
G
 
 
 
i, results in the specific depletion of the DP population
(12). Other G
 
 
 
 protein signaling cascades, including the
G
 
 
 
12 family, are also important for peripheral T cell func-
tion but remain largely unexplored during thymopoiesis.
The G
 
 
 
12 family consists of two members, G
 
 
 
12 and
G
 
 
 
13, which have been reported to mediate actin poly-
merization during T cell activation (16). Differences in
function between these two family members are not well
defined, although G
 
 
 
13 knockout embryos die at day 9
due to defects in angiogenesis, whereas G
 
 
 
12 knockouts
are viable (16, 17). Furthermore, recent work showed that
G2A knockout mice, a GPCR that is known to work spe-
cifically through the G
 
 
 
13 pathway, develop a late onset
autoimmune disorder (18, 19).
The p115RhoGEF protein couples G
 
 
 
13 signaling to
RhoA activation. This protein contains both a regulator of
G protein signaling (RGS) domain enabling specific bind-
ing to either G
 
 
 
12 or G
 
 
 
13, resulting in the activation of
their GTPase activity, and a Dbl homology (DH) domain
that acts as a guanine exchange factor to specifically activate
the small GTPase RhoA (20–22). Both p115RhoGEF and
RhoA have been shown to affect T cell function. Periph-
eral T cells in p115RhoGEF knockout mice hyperprolifer-
ate even in the absence of antigenic stimulation (23). Ex-
tensive research has demonstrated that RhoA is important
in both lymphocyte trafficking and T cell development.
Experiments using the transgenic lck C3 transferase mouse,
which express the RhoA inhibitor C3 transferase under the
control of the lck promoter, revealed a specific require-
ment for RhoA at the DN2 and DN3 stages for survival
(24). C3 transferase expressed under the control of the
CD2 promoter, which is active at a later stage of thy-
mocyte development than that of lck, results in a defect in
differentiation at DN3 (25).
The clear importance of RhoA in thymocyte develop-
ment and G
 
 
 
13’s specific link to RhoA activation led us to
question whether signaling through G
 
 
 
13 or G
 
 
 
12 specifi-
cally plays a role in thymopoiesis. To address this question,
we constructed a retroviral vector expressing a mutant
of p115RhoGEF (p115
 
 
 
DH), which lacks the DH do-
main (amino acids 466–547) and, therefore, cannot activate
RhoA signaling. This mutant acts as a dominant negative of
p115RhoGEF, able to bind both G
 
 
 
12 and G
 
 
 
13 through
the RGS domain to prevent them from transducing a sig-
nal, thus terminating GPCR signaling (26–29). We trans-
duced fetal liver (FL) progenitor cells with vector control
or p115
 
 
 
DH retroviruses and seeded the cells into a thy-
mocyte-depleted fetal thymic lobe. Analysis of cells gener-
ated from the p115
 
 
 
DH seeded mouse fetal thymus organ
cultures (FTOCs) showed a developmental block by DN3.
Using G
 
 
 
12 and G
 
 
 
13 minigenes, we demonstrated that
this block was mediated specifically by G
 
 
 
13. FTOCs
seeded with p115
 
 
 
DH FL progenitor cells also exhibited
reduced prethymocyte proliferation and increased levels of
cell death. Experiments using Bcl2-tg FL progenitor cells
rescued the defect in DN3, demonstrating a role for G
 
 
 
13
in mediating a survival signal during early thymopoiesis.
 
Materials and Methods
 
Animals.
 
All animals were housed at University of North
Carolina-Chapel Hill in a sterile animal facility. FL progenitor
cells were harvested from embryonic day (E)14 or E15 fetuses. Fe-
tal thymic lobes were harvested from E15 fetuses. The Institu-
tional Animal Care and Use Committee approved all experiments.
 
FTOC.
 
FTOC media contains RPMI 1640 (GIBCO BRL)
supplemented with 
 
l
 
-glutamine, 10% FBS, 50 
 
 
 
M 2-mercapto-
ethanol, 2 mM 
 
l
 
-glutamine, 1% nonessential amino acid (GIBCO
BRL), 10 mM Hepes, 1 mM sodium pyruvate solution (GIBCO
BRL), 100 U/ml penicillin, and 100 mg/ml Streptomycin. After
dissection, E15 thymic lobes were cultured at 37
 
 
 
C on membranes
(Millipore), so that the lobe was in contact with 5% CO
 
2
 
. The
lobes were cultured for 5 d in FTOC media supplemented with
2-deoxyguanosine (2-dG; 1.35 mM; Sigma-Aldrich) (30). The lobes
were then washed four times (for 1 h per wash) with PBS/2% FBS
and seeded with GFP
 
 
 
 E14/15 FL progenitor cells. To seed lobes,
10
 
5
 
 GFP
 
 
 
 E14/15 FL cells were cocultured in a Terasaki well with
a single thymic lobe for 48 h (31). The lobes were washed in PBS/
2% FBS and placed onto culture membranes for the indicated
times. The media was changed every other day.
 
Retrovirus Production and Infection.
 
293T cells were trans-
fected with plasmids encoding HSPG retroviral DNA, VSVg,
and gag/pol as described (32). E14/15 FL progenitor cells were
cultured for 24 h in FTOC media supplemented with 50 ng/ml
SCF, IL-6, and 10 ng/ml IL-11 (Peprotech) before transduction.
Retroviral infections by spin inoculation were performed in 2
mL Eppendorf tubes by mixing 2.5 
 
 
 
 10
 
6
 
 cells (500
 
  
 
L FTOC
media with cytokines), viral supernatant (500 
 
 
 
L), and 8 
 
 
 
g/ml
polybrene. Cells were incubated at 22
 
 
 
C for 20 min and centri-
fuged (2,000
 
 g
 
) for 3 h. Cells were sorted for green fluorescent
protein (GFP) expression 48 h after transduction.
 
FACS.
 
GFP-positive FL progenitor cells were sorted on ei-
ther a Cytomation MoFlo FACS or Becton Dickinson FACS Ad-
vantage. Each lobe was crushed (pestle and eppendorf tube), fil-
tered, thymocytes were counted, washed with PBS/2% FBS, and
stained with the indicated antibodies. Total cells harvested per
lobe were analyzed using a Becton Dickinson FACS Caliber.
Hoechst 33342 staining was performed as described previously
(33) and analyzed on a Cytomation MoFlo FACS. Cell death was
measured by harvesting FTOC lobes after 2 wk in culture to pre-
vent progression of thymopoiesis beyond DN3 and stained for
CD25 and annexin V (34). CD4, CD8, and CD3 antibodies were
purchased from Caltag. CD25, CD44, and annexin V antibodies
were purchased from BD Biosciences.
 
Western Blot.
 
Transduced Jurkat cells (10
 
6
 
 cells) or mouse fe-
tal liver cells (10
 
5
 
 cells) were lysed and resolved on a 10% SDS-
PAGE. Gels were transferred to PVDF membranes (Amersham
Biosciences) and blocked with 5% nonfat dry milk. The mem-
brane was probed with 
 
 
 
p115RhoGEF (1:1,000), 
 
 
 
-rabbit–IgG–
HRP (1:10,000) (Amersham Biosciences) and visualized using an
ECL Kit (Amersham Biosciences). The 
 
 
 
p115RhoGEF anti-
body  was produced in rabbits immunized with recombinant
p115RhoGEF protein as described by Hart et al. (35). The blot
was stripped and probed with 
 
 
 
-actin (Sigma-Aldrich), 
 
 
 
-mouse–
IgG–HRP. 
Coffield et al.
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Results
 
The p115
 
 
 
DH Protein Is Not Cytotoxic when Stably Ex-
pressed in Cell Lines and Hematopoietic Progenitor Cells.
 
To
investigate the G
 
 
 
12/13 pathway, we used a dominant
negative p115RhoGEF (p115
 
 
 
DH) in a retroviral vector.
The NH
 
2
 
 terminus of wild-type p115RhoGEF encodes an
RGS domain that functions as a GTPase-activating protein,
which specifically inactivates G
 
 
 
12 and G
 
 
 
13 signaling
(20, 22, 28). The DH domain encodes a guanine nucle-
otide exchange factor (GEF) specific to RhoA activation
and a plextrin homology (PH; reference 36) domain (35)
critical to plasma membrane localization. The deletion of
the DH domain (amino acids 466–547) in p115RhoGEF
(p115
 
 
 
DH) inhibits the protein’s ability to signal down-
stream to RhoA (26, 27, 29, 35). The remaining RGS and
PH domains enable the mutant to inactivate G
 
 
 
12/13 sig-
naling and localize properly to the cytoplasmic membrane,
respectively. The p115
 
 
 
DH construct is expressed from a
murine stem cell virus LTR, and transduced cells were
monitored through a phosphoglycerate kinase–driven en-
hanced GFP marker (Fig. 1 a) (37).
Jurkat T cells transduced with p115
 
 
 
DH exhibited sta-
ble levels of GFP expression over 3 wk in culture (Fig.
1 b). Mouse E15 FL progenitor cells transduced with
p115
 
 
 
DH retained stable levels of GFP expression at least
1 wk in vitro (Fig. 1 c). Jurkat and mouse fetal liver cells
demonstrated stable expression of the p115
 
 
 
DH protein at
days 21 and 7 postretroviral transduction, respectively (Fig.
1 d). This data demonstrates that expression of p115
 
 
 
DH
and subsequent inhibition of G
 
 12/13 signaling does not
negatively affect survival and growth of Jurkat T cells or
primary mouse FL progenitor cells.
G 12/13 Signaling Is Critical for Thymocyte Development.
Although RhoA, a critical component of many different
receptor signaling cascades, including multiple families of
G protein–coupled receptors, has been shown to mediate
proliferation and survival signals during thymopoiesis, it is
not clear which upstream signaling pathways are involved
in the process. The heterotrimeric G protein G 13 has
been clearly shown to be a specific activator of RhoA (28,
38). To address the question of whether G 12/13 signal-
ing played a role in thymocyte development, we expressed
the mutant p115 DH protein that specifically inactivates
G 12/13 signaling (26–28) in the pHSPG retroviral vec-
tor (Fig. 1 a). We used a reconstituted mouse FTOC sys-
tem. E15 FL progenitor cells were transduced, sorted for
GFP expression, and seeded into 2-dG–treated E15 thy-
mic lobes. The lobes were cultured for 3 wk on mem-
branes and analyzed for cell number and expression of
GFP, CD4, and CD8. We observed a significant reduction
(P   0.005) in the percentage and number of GFP  cells
in all lobes seeded with p115 DH FL progenitor cells but
no reduction in the GFP  population (Fig. 2, a and b). Al-
though the percentages of GFP  CD4 CD8 , CD4 CD8 ,
CD4 CD8 , and CD4 CD8  cells were similar between
vector and p115 DH (Fig. 2 c), the p115 DH-seeded
lobes showed an overall decrease in the numbers of GFP 
thymocytes in each population, significant in CD4 CD8 ,
CD4 CD8 , and CD4 CD8  populations (Fig. 2 d).
There was no reduction in the number of any of the
GFP  cell populations (Fig. 2 e). This data indicates a crit-
ical role for G 12/13 signaling during early thymocyte
development.
Figure 1. p115 DH is stably expressed in both
human T cell lines and mouse FL progenitor cells.
(a) The DH domain of the p115RhoGEF was de-
leted to produce p115 DH, which contains only
the RGS and PH domains. The p115 DH was
cloned into a retroviral vector, which also encodes
enhanced GFP under the control of a phosphoglycer-
ate kinase (PGK) promoter. (b) Flow cytometric
analysis of GFP expression in transduced Jurkat T
cells at 2, 11, and 21 d posttransduction. (c) Flow
cytometric analysis of GFP expression in transduced
E14/15 FL progenitor cells at 2 and 7 d posttrans-
duction in culture. (d) 105 transduced Jurkat T cells
and 105 transduced fetal liver cells were analyzed by
Western blot for p115 DH expression at 21 and
8 d posttransduction, respectively.G 13 Is Essential for Thymopoiesis 1318
G 12/13 Signaling Is Important for Early Thymopoiesis.
When the thymocytes were analyzed for DN subsets, the
FTOC system revealed that the expression of p115 DH in
FL progenitor cells generated a lower percentage of cells
preferentially in the DN3 population (Fig. 3 a). However,
there was a significant reduction in the number of DN2
and DN3 cells derived from p115 DH-seeded FTOC
lobes and a general reduction of DN1 and DN4 cells (Fig.
3 b). These results directly demonstrate an essential role for
G 12/13 signaling in early thymopoiesis, most dramatically
at the DN3 stage.
G 13 But Not G 12 Signaling Is Required for Early
Thymopoiesis. The expression of the eleven amino acid
COOH terminus, termed minigene, of a G  protein func-
tions as a specific dominant negative inhibitor of its respec-
tive G  protein by competing for the GPCR binding site
(39–45). To determine if G 12 or G 13 signaling was spe-
cifically required for thymopoiesis, we expressed either a
Figure 2. The expression of p115 DH inhibits T cell development.
2-dG–depleted E15 thymic lobes were seeded with transduced E14/15
FL progenitor cells and cultured for 3 wk. 24 lobes from four different
experiments were analyzed for the percentage (a and b) and the number
(b) of GFP  and GFP  cells. The percentage (c) and number of GFP  (d)
and GFP  (e) CD4 CD8 , CD4 CD8 , CD4 CD8 , and CD4 CD8 
cells generated per lobe were also analyzed. Bars indicate SE; **P   0.005
compared with vector.
Figure 3. The expression of p115 DH inhibits early thymopoiesis.
2-dG–depleted E15 thymic lobes were seeded with transduced E14/15 FL
progenitor cells and cultured as above. (a) Thymocytes that were negative
for expression of CD3, CD4, and CD8 were analyzed for percentages of
CD44 CD25  (DN1), CD44 CD25  (DN2), CD44 CD25  (DN3),
and CD44 CD25  (DN4). (b) The total number of DN1, DN2, DN3,
and DN4 cells generated per lobe from four lobes for vector or p115 DH
is summarized. The data is representative of four independent experiments.
Bars indicate SE; *P   0.05; **P   0.005 compared with vector.Coffield et al. 1319
G 12 or G 13 minigene fused to GFP in the FTOC sys-
tem. The G 13 minigene, but not the G 12 minigene,
paralleled the p115 DH phenotype by significantly reduc-
ing the total number of GFP  thymocytes (Fig. 4 a). Early
thymocyte populations were also inhibited in the G 13
minigene reconstituted FTOCs similarly to the phenotype
seen using p115 DH (Fig. 4, b and c). The combination of
the p115 DH and G 13 minigene results suggests that the
block in thymopoiesis is a result of the specific inhibition of
G 13 signaling.
The Inhibition of G 13 Signaling Results in Decreased DN
Proliferation and Increased Cell Death. The reduction in the
number of prethymocytes derived from the p115 DH-
seeded FTOCs led us to question whether G 13 signaling
could be involved in proliferation or survival of these cells.
Hoechst staining of p115 DH-derived thymocyte progen-
itor cells showed a decrease in the percentage of cells in
S/G2 for all DN populations (Fig. 5 a). This decrease dem-
Figure 4. The expression of the G 13 minigene, but not the G 12 mini-
gene, inhibits early thymopoiesis. Six FTOC lobes for vector or p115 DH
were individually analyzed to determine the total number of GFP  (a), total
CD3 CD4 CD8  (b), and DN1, DN2, DN3, and DN4 (c) cells generated
per lobe. The data is representative of two independent experiments. Bars
indicate SE; *P   0.05 compared with vector.
Figure 5. The inhibition of G 13 signaling results in decreased DN
proliferation and increased cell death. 2-dG–depleted E15 thymic lobes
were seeded with transduced E14/15 FL progenitor cells. (a) Duplicate
pooled samples consisting of six lobes for both vector and p115 DH
were stained with Hoechst 33342 and CD3/CD4/CD8/CD25/CD44.
At least 5   105 GFP  cells were analyzed to determine the percentage of
cells with greater than 2N DNA (S/G2 phases). (b and c) Three lobes for
vector or p115 DH were harvested after 2 wk in FTOC culture when
most thymocytes are between DN1-DN3. Thymocytes were gated on
CD25  (DN2, DN3) or CD25  (DN1) and individually analyzed for
annexin V mean fluorescence intensity (MFI) and percentage of annexin
V  cells generated per lobe. Bars indicate SE, and p-values are indicated.G 13 Is Essential for Thymopoiesis 1320
onstrated that inhibition of G 13 signaling resulted in low-
ered proliferation of prethymocytes, most obviously in
DN1 and DN4 cells. To look at cell death, we harvested
fetal liver seeded lobes at 2 wk and stained the cells with
annexin V as a marker of apoptosis. At the 2 wk time
point, few progenitor cells have progressed past DN3 (un-
published data), allowing us to look at cell death exclu-
sively in prethymocytes. We stained cells with anti-CD25
to separate DN1 from DN2/3. Cells harvested from
p115 DH-seeded lobes showed an increase in annexin V
staining in both CD25  and CD25  populations compared
with vector (Fig. 5, b and c). This data indicated that the
thymic phenotype generated through the inhibition of
G 13 signaling was a combination of reduced DN prolifer-
ation and increased cell death.
TCR Stimulation Fails to Compensate for the Loss of G 13
Signaling in Thymopoiesis. RhoA signaling has been impli-
cated to be downstream of the pre-TCR, though expres-
sion of constitutively active RhoA is not sufficient to res-
cue a defect in pre-TCR signaling (46, 47). In addition,
during the DN2/DN3 stages of development the pre-
TCR signal serves as a checkpoint for further cell expan-
sion. We asked whether enhancing TCR signaling could
compensate for the loss of G 13 signaling in thymopoiesis.
FTOC assays were performed in the presence of anti-CD3
mAb during the last 7 d in culture. Vector control lobes
treated with anti-CD3 demonstrated a significant increase
in the total number of recovered thymocytes compared
with untreated controls. However, p115 DH lobes showed
no difference between cultures treated with or without
anti-CD3 (Fig. 6 a). Individual DN3 and DN4 populations
showed significant increases in vector lobes treated with
Figure 6. TCR stimulation does not rescue the block in thymopoiesis.
2-dG–depleted E15 thymic lobes were seeded with transduced E14/15
FL progenitor cells and cultured for 2 wk. Lobes were stimulated with
10  g/ml of anti-CD3 mAb from day 14 to 21 in culture. Fresh media
containing anti-CD3 was added every 2 d. Six lobes per sample were in-
dividually analyzed to determine the total number of GFP  (a) and DN1,
DN2, DN3, and DN4 (b) cells generated per lobe. Bars indicate SE; *P  
0.05; **P   0.005 as vector or p115DDH samples compared with unstim-
ulated controls.
Figure 7. Overexpression of Bcl2 rescues the block in DN3 development.
2-dG–depleted E15 thymic lobes were seeded with wild-type or littermate
Bcl2-tg E15 FL progenitor cells transduced with vector or p115 DH and
cultured for 3 wk. Six lobes per sample were individually analyzed to deter-
mine the number of total GFP  (a), total CD3 CD4 CD8  (b), and DN1,
DN2, DN3, and DN4 (c) cells generated per lobe. Bars indicate SE; *P  
0.05; **P   0.005 compared with vector.Coffield et al. 1321
anti-CD3 compared with untreated, but again no increase
was observed in p115 DH lobes (Fig. 6 b). The block in
G 13 signaling cannot be overcome through exogenous
TCR signaling, placing G 13 signaling in a pathway dis-
tinct from the pre-TCR signaling.
Overexpression of Bcl2 Rescues the Block in G 13 Signaling
during Thymopoiesis. The inhibition of RhoA in the lck
C3 transferase transgenic mouse model revealed a critical
role for RhoA signaling during DN3 cell development,
which can be rescued by overexpression of Bcl2 (24). To
address whether G 13 signaling is also acting through a
survival pathway, we used Bcl2-tg FL progenitor cells
to reconstitute FTOCs. Wild-type littermate controls re-
peated the initial observation that p115 DH inhibited thy-
mopoiesis and specifically reduced the number of both total
and DN cells (Fig. 7, a and b). Bcl2-tg FL progenitor cells
expressing p115 DH showed a partial but significant res-
cue of total thymopoiesis (Fig. 7 a) and most obviously of
DN3 thymocytes (Fig. 7 c). This rescue defines a critical
role for G 13 signaling in the survival of early thymocyte
progenitors specifically by the DN3 stage of development.
Although expression of Bcl2 rescued DN3 development in
p115 DH-seeded FTOCs, we still observed a difference in
cell number between vector and p115 DH in the DN1
and DN4 populations (Fig. 7 c). The inability of DN1and
DN4 populations to be rescued by Bcl2 may be explained
by a reduction in prethymocyte proliferation (Fig. 5 a).
These data demonstrate the critical role of G 13 signaling
in the survival of DN3 cells and in the proliferation of cells
during DN1 and DN4.
Discussion
Although previous studies have clearly identified multiple
roles for RhoA signaling in thymocyte development (24,
25, 48), it is not clear which upstream signaling pathways
are involved in activating RhoA in the thymus. We have
shown that blocking G 13 signaling inhibits thymopoiesis
by using a dominant negative mutant of p115RhoGEF
(p115 DH) to block G 12 and G 13 signaling in T cell
progenitors. Cells expressing p115 DH fail to expand to
wild-type levels in FTOC assays. By using G 12 and G 13
minigenes (39–45), we were able to demonstrate that G 13
but not G 12 was involved in thymopoiesis. In addition,
G 13 signaling was shown to be important for the prolifer-
ation and survival of thymocyte progenitors.
The phenotype observed using the p115 DH mutant in
our FTOC system is similar, although not identical, to the
thymic phenotype seen in the lck-C3 transferase transgenic
mouse. It has been reported recently that RhoA mediates a
p53-dependent checkpoint at the DN3 stage of thymocyte
development, which prevents cells with nonproductive
TCR  rearrangements from progressing to the DP stage
(47). Though pre-TCR signaling is also important for pro-
gressing past the p53-mediated checkpoint, evidence sug-
gests that RhoA signaling acts independently of the TCR
signaling pathway to affect survival (47). This is consistent
with our finding that stimulation of the pre-TCR with
anti-CD3 does not rescue the defect in the G 13-mediated
proliferation and survival signals. Bcl2, a member of a large
family of pro- and antiapoptotic factors, has been shown to
prevent the death of immature thymocytes in response to
many signals including dexamethasone treatment, CD3
stimulation, and radiation (49). By using FL progenitor
cells constitutively expressing Bcl2 (50), we were able to
partially rescue the effect of blocking G 13 signaling on
thymocyte development, indicating that G 13 is transduc-
ing a survival signal during thymopoiesis.
However, this rescue does not rule out a role for G 13
in proliferation of cells at different points in development.
Hoechst staining of thymocytes derived from p115 DH-
seeded FTOCs showed a decrease in the proliferation of
cells at each DN stage, most obviously at DN1 and DN4.
Interestingly, Bcl2 expression rescued the defect in DN3
but not DN1 and DN4 by p115 DH. Further evidence
for an important role for G 13 in cell death is the increased
annexin V staining in cells expressing p115 DH. The lck-
C3 transferase mouse has a similar phenotype—large amounts
of apoptosis during DN2 and DN3 followed by a defect in
the ability of surviving DN4 cells to proliferate (25, 47).
Although the lck-C3 transferase mouse also shows an accu-
mulation of cells at DN1 which we do not see, this may be
the result of continuous reseeding of the thymus in the
transgenic mouse that we are unable to account for in the
FTOC system. Additionally, blocking G 13 signaling does
not preclude RhoA activation by other pathways, making
differences between the phenotypes unsurprising. Never-
theless, similarities between the phenotypes suggest that a
critical G 13 signal in early thymopoiesis uses RhoA acti-
vation to mediate its effect.
RhoA is a clear candidate as a downstream effector for
the G 13 thymocyte survival pathway since biochemical
and cell biological evidence has been reported that G 13
specifically activates RhoA but not Rac or Cdc42 (27, 28,
51). However, potential upstream components that lead to
G 13 activation are not as well established (52). Numerous
GPCRs are expressed in lymphoid tissues that can activate
RhoA and other Rho family GTPases including Rac and
Cdc42, though few of them signal through G 13 (53, 54).
However, the G2A receptor is a GPCR that is expressed
predominantly in lymphocytes, including thymocytes (55),
and couples specifically to G 13 (51). Mice with a deletion
in G2A develop late onset autoimmunity, indicating a role
for the receptor in development and function of T cells
(19). Though ligands that bind exclusively to G2A have not
been determined, recent work has identified lysophosphati-
dylcholine (LPC) as a potent activator of the receptor (18).
Although it is reported that LPC stimulates chemotaxis of
cells expressing G2A and inducing intracellular Ca2  influx,
the lysophospholipid is generally believed to be involved in
the modulation of immune response. High concentrations
(up to 100  M) of LPC are present in bodily fluids though
most of the lipid is probably in an inactive form (55). The
expression pattern of G2A on thymocytes, the receptor’s
known involvement in T cell proliferation and autoimmu-
nity, and the widespread availability of LPC in the body to-G 13 Is Essential for Thymopoiesis 1322
gether makes G2A an attractive candidate for activating the
G 13 signaling pathway in thymopoiesis. Preliminary data
in our lab indicated that the addition of LPC to FTOCs
stimulated thymocyte production during early thymocyte
development (unpublished data). Alternatively, several re-
ceptors closely related to G2A that also bind LPC, includ-
ing the sphingosylphosphorylcholine receptors (55), may be
additional candidates relevant to G 13-mediated survival
signaling in early thymocytes.
Two other proteins that are known to be important in
early thymocyte survival are IL-7 and c-kit (56). Although
both IL-7 /  and IL-7R  /  mice exhibit impaired thy-
mic cellularity, neither mutation completely blocks thy-
mopoiesis (57, 58). Interestingly, Bcl2 is able to partially
rescue the thymocyte phenotype in mice deficient in IL-7
signaling, though the rescue is incomplete (59). Lack of
c-kit causes a decrease in thymocyte numbers as early as the
DN1 stage (60). Evidence suggests that c-kit is involved in
thymocyte proliferation since mice lacking c-kit signaling
show a 50% decrease in BrdU incorporation compared
with wild-type controls, although a definitive role for c-kit
in thymocyte survival has not been established (56). The
IL-7 and c-kit signaling pathways can compensate for each
other in vivo since mice lacking both c-kit and IL-7 recep-
tor common chain ( c) fail to develop T lymphocytes (56).
As described above, we see a partial rescue of thymopoiesis
in p115 DH-expressing cells in the presence of Bcl2. It is
possible that G 13 signaling may interact with one or both
of these receptor kinase signaling pathways to promote sur-
vival in developing thymocytes.
Our data shows the first evidence that G 13-mediated
signaling plays an important role in the proliferation and
survival of thymocytes during development. This pathway
may also have an important role in the T cell response in
the periphery. The discovery that G 13 signaling is able to
influence thymocyte maturation not only increases our un-
derstanding of T cell development but also opens novel av-
enues for modulating thymopoiesis and investigating other
points in the T cell life cycle where G 13 might have an
important regulatory role.
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